Table 4.
Predictor variables | ßCrude (OR) | ßAdjusted (OR) | 95% CI for difference* |
|
---|---|---|---|---|
lower | upper | |||
Age | 1.05** | 1.05** | 1.01 | 1.09 |
Gender | 0.92 | 0.74 | 0.36 | 1.57 |
Hawalli | 1.07 | |||
Al-Farwaniya | 1.21 | |||
Mubarak Al-Kabir | 0.73 | |||
Work status | 0.62 | |||
Smoker | 0.91 | 0.69 | 0.23 | 2.07 |
Diabetes | 0.4** | 0.42** | 0.23 | 0.75 |
Hypertension | 0.50* | |||
Zocor | 1.64 | |||
Crestor | 0.29 | |||
Statin duration | 1.04* | |||
Depression | 0.98 | |||
Anxiety | 0.96 | |||
Stress | 0.99 | |||
χ2lr (d.f. = 4) | 17.97 | |||
p value (χ2lr) | 0.0013 |
Al-Asimah and treatment with atorvastatin are not shown in the table as they are the referents (the group against which the others are compared) for the remaining governorates (Hawalli, Al-Farwaniya, Mubarak Al-Kabir) and statins (Zocor, Crestor).
p< 0.05
p< 0.01.